Clinical Trials Directory

Trials / Completed

CompletedNCT06245382

The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive Health

The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
The University of Texas at Arlington · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The overall research objective of this proposal is to determine the acute and chronic impact of daily supplementation of a Good Health beverage on indices of physiological and neurocognitive health.

Detailed description

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality and affects all individuals. There are many primary risk factors for CVD with some of the primary causes including hypertension, hypercholesteremia, atherosclerosis, and type 2 diabetes mellitus. Furthermore, the rise in the prevalence of various neurocognitive conditions and cerebral vascular diseases including cognitive dysfunction, dementia, stroke, and Alzheimer's disease requires additional attention from a research perspective. While the reasons contributing to CVD and neurocognitive complications/cerebral vascular diseases, is multifactorial, a common link is impaired vascular function. A hallmark of impaired vascular function is elevated arterial stiffness and a decrease in the vasodilator capacity in the brain and periphery. Reduced nitric oxide (NO) bioavailability, due to elevated oxidative stress and systemic inflammation is implicated as a primary contributing factor for these attenuated vasodilatory responses. Therefore, it is reasonable to speculate that an approach targeting these pathways could abolish or minimize this elevated risk. One such approach could be increased dietary consumption of a naturally based product that is high in polyphenol content and ingredients that are well-known to have beneficial effects on oxidative stress, inflammation, blood lipids etc. In turn this would be expected to have beneficial outcomes on various biomarkers associated with peripheral and cerebral vascular health including, cholesterol, lipid profile, insulin sensitivity/type II diabetes, cognitive health, arterial stiffness, blood pressure, and NO bioavailability and subsequently vascular function/health. Specifically, the Goode Health Super Food Smoothie Blend is a product that we are interested in investigating in this proposal. 1. Primary Aim - The primary endpoint is the effect of increased daily consumption of the Good Health beverage on outcomes associated with elevated risk for various neurocognitive and pathophysiological conditions/diseases. These outcomes include cognitive function, central and peripheral arterial blood pressure, cerebral and peripheral blood vessel function/health, and blood biomarkers (e.g., indices of inflammation, oxidative stress, insulin resistance/diabetes risk, and lipid profile). 2. Secondary Aim - A secondary endpoint is the effect of daily consumption of the Good Health beverage on the following variables: waist circumference, body weight, and body mass index (BMI).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGoode Health BeverageThis is a commercially available beverage powder that is high is healthy ingredients that are believed to be beneficial for physiological health.
DIETARY_SUPPLEMENTVanilla Base Beverage BlendThis is a commercially available beverage powder.

Timeline

Start date
2023-10-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-02-07
Last updated
2025-04-01

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06245382. Inclusion in this directory is not an endorsement.